| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10032254 | American Journal of Obstetrics and Gynecology | 2005 | 7 Pages |
Abstract
Hormone replacement therapy used according to current recommendations should not increase risk of ovarian cancer; however, clinicians should be aware of possible increased risk among women with a long history of estrogen replacement therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Patricia G. PhD, Joellen M. PhD, Brian MS, Susan PhD, Andrew MD,